Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Failure Of Roche’s Nine-Year Alzheimer’s Prevention Study Disappointing, But No Surprise
Crenezumab Fails Again
Jun 16 2022
•
By
Andrew McConaghie
The nine year study was carried out in the Antioquia region of Colombia, where a genetic mutation makes some people almost certain to develop Alzheimer’s disease.. • Source: Shutterstock
More from Neurological
More from Therapeutic Category